BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18561143)

  • 1. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
    Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of drug eluting stents with bare metal stents in daily practice for bifurcation lesions in Chinese patients.
    Kang S; Yang YJ; Xu B; Chen JL; Qiao SB; Yao M; Chen J; Wu YJ; Liu HB; Dai J; Yuan JQ; Li JJ; Gao RL
    Chin Med J (Engl); 2006 Jul; 119(14):1157-64. PubMed ID: 16863606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
    Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions.
    Price MJ; Sawhney N; Kao JA; Madrid A; Schatz RA; Teirstein PS
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):208-11. PubMed ID: 15880798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.
    Ge L; Iakovou I; Sangiorgi GM; Chieffo A; Melzi G; Cosgrave J; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Colombo A
    J Am Coll Cardiol; 2005 Apr; 45(7):989-94. PubMed ID: 15808752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and mid-term results of drug-eluting stent implantation in unprotected left main.
    Chieffo A; Stankovic G; Bonizzoni E; Tsagalou E; Iakovou I; Montorfano M; Airoldi F; Michev I; Sangiorgi MG; Carlino M; Vitrella G; Colombo A
    Circulation; 2005 Feb; 111(6):791-5. PubMed ID: 15699254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials.
    Moses JW; Stone GW; Nikolsky E; Mintz GS; Dangas G; Grube E; Ellis SG; Lansky AJ; Weisz G; Fahy M; Na Y; Russell ME; Donohoe D; Leon MB; Mehran R
    J Am Coll Cardiol; 2006 Jun; 47(11):2164-71. PubMed ID: 16750680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.
    Chu WW; Rha SW; Kuchulakanti PK; Cheneau E; Torguson R; Pinnow E; Alexieva-Fournadjiev J; Pichard AD; Satler LF; Kent KM; Lindsay J; Waksman R
    Am J Cardiol; 2006 Jan; 97(1):34-7. PubMed ID: 16377280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.
    Stankovic G; Colombo A; Presbitero P; van den Branden F; Inglese L; Cernigliaro C; Niccoli L; Bartorelli AL; Rubartelli P; Reifart N; Heyndrickx GR; Saunamäki K; Morice MC; Sgura FA; Di Mario C;
    Circulation; 2003 Jul; 108(1):37-42. PubMed ID: 12821546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction.
    Gioia G; Matthai W; Benassi A; Rana H; Levite HA; Ewing LG
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):392-8. PubMed ID: 16892436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
    Ashfaq S; Ghazzal Z; Douglas JS; Morris DC; Veledar E; Weintraub WS
    J Invasive Cardiol; 2006 Mar; 18(3):100-5. PubMed ID: 16598106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts.
    Buch AN; Xue Z; Gevorkian N; Torguson R; Fournadjieva J; Deible R; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2006 Sep; 98(6):722-4. PubMed ID: 16950170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis.
    Mishra S; Wolfram RM; Torguson R; Chu WW; Xue Z; Gevorkian N; Donekal S; Chan R; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 May; 97(9):1303-7. PubMed ID: 16635600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
    Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
    Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.
    Park DW; Park SW; Park KH; Lee BK; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2006 Aug; 98(3):352-6. PubMed ID: 16860022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
    Moreno R; Fernández C; Hernández R; Alfonso F; Angiolillo DJ; Sabaté M; Escaned J; Bañuelos C; Fernández-Ortiz A; Macaya C
    J Am Coll Cardiol; 2005 Mar; 45(6):954-9. PubMed ID: 15766835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.